ArticleAmino acids2026
Assessment of molecular interactions and anti-inflammatory activity of fermented camel milk-derived peptides in RAW macrophages.
Article in Amino acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fermented camel milk is gaining attention as a functional food due to the formation of bioactive peptides during microbial fermentation. This study aimed to investigate the generation of bioactive peptides and their associated antidiabetic, antioxidant, and anti-inflammatory activities in camel milk fermented using Lacticaseibacillus rhamnosus M9 and Saccharomyces cerevisiae WBS2A. The in vitro fermentation process was evaluated in relation to proteolytic activity and peptide formation under varying fermentation times and inoculum concentrations. Antidiabetic activity was assessed using α-amylase and α-glucosidase inhibition assays, while antioxidant potential was determined using the ABTS assay. Peptide profiles and metabolite changes were characterized using RP-HPLC, SDS-PAGE, and 2D electrophoresis, and structural modifications were analysed through FTIR and CLSM. Fermentation significantly enhanced proteolytic activity, leading to the release of low-molecular-weight peptides (3-10 kDa) associated with improved bioactivity. Fermented samples exhibited notable α-amylase (70.68%) and α-glucosidase (59.18%) inhibition, along with maximum antioxidant activity (54.97%) after 48 h. In addition, fermented camel milk reduced intracellular ROS, pro-inflammatory cytokines, and apoptosis in LPS-stimulated RAW 264.7 macrophages. Molecular docking analysis further suggested potential interactions between identified peptides and target enzymes, supporting the observed in vitro activities.These findings demonstrate that fermentation-derived peptides contribute to the functional properties of camel milk; however, further in vivo studies are required to confirm their bioavailability and therapeutic relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.